• U.S. FDA Approves First Injectable Treatment for Cellulite

    2 monthes ago - By Surgical Aesthetics Magazine

    Endo International has received U.S. Food and Drug Administration approval of QWO (collagenase clostridium histolyticum-aaes) for the treatment of moderate to severe cellulite in the buttocks of adult women. QWO is the first FDA-approved injectable treatment for cellulite. When injected into the treatment area, QWO enzymatically releases the fibrous septae that tether to the skin causing the dimpling of cellulite by specifically targeting Types 1 and 3 collagen.
    “Endo recognized a significant unmet need for an effective and noninvasive injectable treatment for cellulite, which led us to...
    Read more ...